gip/glp-1 drugs Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements The Effects of Dual GLP-1/GIP
Description
doi: 10.1016/bs.pbr.2019.10.008
Inflamm Bowel Dis 22:20782097
13 The median expected protection we determined for GLP-1 receptor agonistswhich exceeds 18 yearsis the highest yet reported for drug-device combinations
2021;11:e12433
Interesting to see how this behaves as a commercial product
